Overview

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of the combination of etanercept 50 mg once weekly plus methotrexate with that of methotrexate monotherapy in the treatment of rheumatoid arthritis over 88 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Etanercept
Methotrexate